ATHENEX, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 330 rows in 2023. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2023-05-08: Reporting owner LAU JOHNSON YIU NAM; Form 4; Security Stock Option (Right to Buy); Transaction Holding.
- 2023-05-08: Reporting owner LAU JOHNSON YIU NAM; Form 4; Security Stock Option (Right to Buy); Transaction Holding.
- 2023-05-08: Reporting owner LAU JOHNSON YIU NAM; Form 4; Security Stock Option (Right to Buy); Transaction Holding.
- 2023-05-08: Reporting owner LAU JOHNSON YIU NAM; Form 4; Security Stock Option (Right to Buy); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-05-08 holding as of filing | LAU JOHNSON YIU NAM Director, Officer (CEO and Chairman of the Board) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 70,000 owned after | $150.00 exercise price | 2023-05-08 | |
| 2023-05-08 holding as of filing | LAU JOHNSON YIU NAM Director, Officer (CEO and Chairman of the Board) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 1 owned after | $220.00 exercise price | 2023-05-08 | |
| 2023-05-08 holding as of filing | LAU JOHNSON YIU NAM Director, Officer (CEO and Chairman of the Board) | 4 | Stock Option (Right to Buy) Derivative · Indirect · (m) | Holding | 2,746 owned after | $180.00 exercise price | 2023-05-08 | |
| 2023-05-08 holding as of filing | LAU JOHNSON YIU NAM Director, Officer (CEO and Chairman of the Board) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 12,500 owned after | $346.00 exercise price | 2023-05-08 | |
| 2023-05-08 holding as of filing | LAU JOHNSON YIU NAM Director, Officer (CEO and Chairman of the Board) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 12,500 owned after | $263.40 exercise price | 2023-05-08 | |
| 2023-05-08 holding as of filing | LAU JOHNSON YIU NAM Director, Officer (CEO and Chairman of the Board) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 2,753 owned after | $146.40 exercise price | 2023-05-08 | |
| 2023-05-08 holding as of filing | LAU JOHNSON YIU NAM Director, Officer (CEO and Chairman of the Board) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 15,000 owned after | $249.00 exercise price | 2023-05-08 | |
| 2023-05-08 holding as of filing | LAU JOHNSON YIU NAM Director, Officer (CEO and Chairman of the Board) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 7,500 owned after | $76.00 exercise price | 2023-05-08 | |
| 2023-05-08 holding as of filing | LAU JOHNSON YIU NAM Director, Officer (CEO and Chairman of the Board) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 12,500 owned after | $13.31 exercise price | 2023-05-08 | |
| 2023-05-08 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 2,400 owned after | $91.00 exercise price | 2023-05-08 | |
| 2023-05-08 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 6,000 owned after | $91.00 exercise price | 2023-05-08 | |
| 2023-05-08 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 2,400 owned after | $91.00 exercise price | 2023-05-08 | |
| 2023-05-08 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 10,000 owned after | $110.00 exercise price | 2023-05-08 | |
| 2023-05-08 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 6,000 owned after | $150.00 exercise price | 2023-05-08 | |
| 2023-05-08 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 7,000 owned after | $220.00 exercise price | 2023-05-08 | |
| 2023-05-08 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 6,000 owned after | $346.00 exercise price | 2023-05-08 | |
| 2023-05-08 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 6,000 owned after | $263.40 exercise price | 2023-05-08 | |
| 2023-05-08 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 7,000 owned after | $249.00 exercise price | 2023-05-08 | |
| 2023-05-08 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 3,500 owned after | $76.00 exercise price | 2023-05-08 | |
| 2023-05-08 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 3,750 owned after | $13.31 exercise price | 2023-05-08 | |
| 2023-05-08 holding as of filing | Cook Timothy DeVere Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 3,500 owned after | $345.80 exercise price | 2023-05-08 | |
| 2023-05-08 holding as of filing | Cook Timothy DeVere Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 1,500 owned after | $205.20 exercise price | 2023-05-08 | |
| 2023-05-08 holding as of filing | Cook Timothy DeVere Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 450 owned after | $71.20 exercise price | 2023-05-08 | |
| 2023-05-08 holding as of filing | Cook Timothy DeVere Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 3,750 owned after | $13.31 exercise price | 2023-05-08 | |
| 2023-04-24 holding as of filing | WU JINN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 500 owned after | $91.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | WU JINN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 2,700 owned after | $110.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | WU JINN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 4,800 owned after | $110.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | WU JINN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 1,425 owned after | $220.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | WU JINN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 825 owned after | $346.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | WU JINN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 750 owned after | $263.40 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | WU JINN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 625 owned after | $249.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | WU JINN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 375 owned after | $76.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | WU JINN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 750 owned after | $9.14 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | VIERLING JOHN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 500 owned after | $241.20 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | VIERLING JOHN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 125 owned after | $229.80 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | VIERLING JOHN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 625 owned after | $249.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | VIERLING JOHN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 375 owned after | $76.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | VIERLING JOHN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 875 owned after | $9.14 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | TSANG Benson Kwan Hung Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 488 owned after | $390.20 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | TSANG Benson Kwan Hung Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 875 owned after | $263.40 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | TSANG Benson Kwan Hung Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 1,000 owned after | $249.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | TSANG Benson Kwan Hung Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 500 owned after | $76.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | TSANG Benson Kwan Hung Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 1,000 owned after | $9.14 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Spiegel Robert J. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 365 owned after | $228.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Spiegel Robert J. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 438 owned after | $76.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Spiegel Robert J. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 875 owned after | $9.14 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | LAU JOHNSON YIU NAM Director, Officer (CEO and Chairman of the Board) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 70,000 owned after | $150.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | LAU JOHNSON YIU NAM Director, Officer (CEO and Chairman of the Board) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 1 owned after | $220.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | LAU JOHNSON YIU NAM Director, Officer (CEO and Chairman of the Board) | 4 | Stock Option (Right to Buy) Derivative · Indirect · (m) | Holding | 2,746 owned after | $180.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | LAU JOHNSON YIU NAM Director, Officer (CEO and Chairman of the Board) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 12,500 owned after | $346.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | LAU JOHNSON YIU NAM Director, Officer (CEO and Chairman of the Board) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 12,500 owned after | $263.40 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | LAU JOHNSON YIU NAM Director, Officer (CEO and Chairman of the Board) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 2,753 owned after | $146.40 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | LAU JOHNSON YIU NAM Director, Officer (CEO and Chairman of the Board) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 15,000 owned after | $249.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | LAU JOHNSON YIU NAM Director, Officer (CEO and Chairman of the Board) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 7,500 owned after | $76.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | LAU JOHNSON YIU NAM Director, Officer (CEO and Chairman of the Board) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 12,500 owned after | $13.31 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 2,400 owned after | $91.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 6,000 owned after | $91.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 2,400 owned after | $91.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 10,000 owned after | $110.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 6,000 owned after | $150.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 7,000 owned after | $220.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 6,000 owned after | $346.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 6,000 owned after | $263.40 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 7,000 owned after | $249.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 3,500 owned after | $76.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 3,750 owned after | $13.31 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Fok Manson Director | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 2,400 owned after | $91.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Fok Manson Director | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 1,000 owned after | $91.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Fok Manson Director | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 2,000 owned after | $91.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Fok Manson Director | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 2,400 owned after | $150.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Fok Manson Director | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 2,400 owned after | $180.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Fok Manson Director | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 1,350 owned after | $220.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Fok Manson Director | 4 | Stock Option (Right to Buy) Derivative · Indirect · (m) | Holding | 2,746 owned after | $180.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Fok Manson Director | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 750 owned after | $346.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Fok Manson Director | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 500 owned after | $263.40 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Fok Manson Director | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 500 owned after | $249.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Fok Manson Director | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 313 owned after | $76.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Fok Manson Director | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | 625 owned after | $9.14 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Davis Stephanie A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 500 owned after | $241.20 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Davis Stephanie A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 375 owned after | $229.80 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Davis Stephanie A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 875 owned after | $249.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Davis Stephanie A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 438 owned after | $76.00 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Davis Stephanie A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 875 owned after | $9.14 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Cook Timothy DeVere Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 3,500 owned after | $345.80 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Cook Timothy DeVere Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 1,500 owned after | $205.20 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Cook Timothy DeVere Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 450 owned after | $71.20 exercise price | 2023-04-24 | |
| 2023-04-24 holding as of filing | Cook Timothy DeVere Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 3,750 owned after | $13.31 exercise price | 2023-04-24 | |
| 2023-04-11 holding as of filing | Cook Timothy DeVere Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 3,500 owned after | $345.80 exercise price | 2023-04-11 | |
| 2023-04-11 holding as of filing | Cook Timothy DeVere Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 1,500 owned after | $205.20 exercise price | 2023-04-11 | |
| 2023-04-11 holding as of filing | Cook Timothy DeVere Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 450 owned after | $71.20 exercise price | 2023-04-11 | |
| 2023-04-11 holding as of filing | Cook Timothy DeVere Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 3,750 owned after | $13.31 exercise price | 2023-04-11 | |
| 2023-04-11 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 2,400 owned after | $91.00 exercise price | 2023-04-11 | |
| 2023-04-11 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 6,000 owned after | $91.00 exercise price | 2023-04-11 | |
| 2023-04-11 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 2,400 owned after | $91.00 exercise price | 2023-04-11 | |
| 2023-04-11 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 10,000 owned after | $110.00 exercise price | 2023-04-11 | |
| 2023-04-11 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 6,000 owned after | $150.00 exercise price | 2023-04-11 | |
| 2023-04-11 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 7,000 owned after | $220.00 exercise price | 2023-04-11 | |
| 2023-04-11 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 6,000 owned after | $346.00 exercise price | 2023-04-11 | |
| 2023-04-11 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 6,000 owned after | $263.40 exercise price | 2023-04-11 | |
| 2023-04-11 holding as of filing | Kwan Rudolf Officer (EVP, Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | Holding | 7,000 owned after | $249.00 exercise price | 2023-04-11 |